- Home
- LAKE vs IPSC Comparison
LAKE vs IPSC Comparison
Compare LAKE & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LAKE
- IPSC
- Stock Information
- Founded
- LAKE 1982
- IPSC 2019
- Country
- LAKE United States
- IPSC United States
- Employees
- LAKE N/A
- IPSC N/A
- Industry
- LAKE Industrial Specialties
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- LAKE Health Care
- IPSC Health Care
- Exchange
- LAKE Nasdaq
- IPSC Nasdaq
- Market Cap
- LAKE 180.8M
- IPSC 49.6M
- IPO Year
- LAKE 1986
- IPSC 2021
- Fundamental
- Price
- LAKE $14.32
- IPSC $0.60
- Analyst Decision
- LAKE Strong Buy
- IPSC Strong Buy
- Analyst Count
- LAKE 3
- IPSC 5
- Target Price
- LAKE $26.00
- IPSC $3.33
- AVG Volume (30 Days)
- LAKE 297.9K
- IPSC 1.0M
- Earning Date
- LAKE 09-03-2025
- IPSC 08-07-2025
- Dividend Yield
- LAKE 0.83%
- IPSC N/A
- EPS Growth
- LAKE N/A
- IPSC N/A
- EPS
- LAKE N/A
- IPSC N/A
- Revenue
- LAKE $177,648,000.00
- IPSC $114,898,000.00
- Revenue This Year
- LAKE $32.98
- IPSC $1,064.82
- Revenue Next Year
- LAKE $4.70
- IPSC N/A
- P/E Ratio
- LAKE N/A
- IPSC N/A
- Revenue Growth
- LAKE 34.28
- IPSC 8286.72
- 52 Week Low
- LAKE $12.76
- IPSC $0.34
- 52 Week High
- LAKE $27.28
- IPSC $3.29
- Technical
- Relative Strength Index (RSI)
- LAKE 44.51
- IPSC 55.47
- Support Level
- LAKE $13.38
- IPSC $0.52
- Resistance Level
- LAKE $14.82
- IPSC $0.57
- Average True Range (ATR)
- LAKE 0.64
- IPSC 0.04
- MACD
- LAKE 0.24
- IPSC 0.00
- Stochastic Oscillator
- LAKE 72.86
- IPSC 66.10
About LAKE Lakeland Industries Inc.
Lakeland Industries Inc manufactures and sells safety garments and accessories for the industrial protective clothing market. Its product segments include Disposables, Chemicals, Fire, Gloves, High Visibility, High-Performance Wear, and Wovens. Its customers include integrated oil, chemical/petrochemical, utilities, automobile, steel, glass, construction, smelting, munition plants, janitorial, pharmaceutical, and mortuaries, as well as scientific and medical laboratories. Its geographical segments include the United States, Latin America, Canada, Asia, Mexico, Europe (United Kingdom), and Other Foreign.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.